UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 99

of 'Chemotherapy for advanced exocrine pancreatic cancer'

99
TI
Does a statistically significant survival benefit of erlotinib plus gemcitabine for advanced pancreatic cancer translate into clinical significance and value?
AU
Miksad RA, Schnipper L, Goldstein M
SO
J Clin Oncol. 2007;25(28):4506.
 
AD
PMID